or
forgot password

    • cancer clinical trials in urbana, IL

    • Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Lymphoma
    Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma With Sarcomatoid Features
    Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Lymphoma
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Carle Cancer Center at Carle Foundation Hospital
    Urbana, Illinois 61801
    Pancreatic Cancer
    Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
    CCOP - Carle Cancer Center
    Urbana, Illinois 61801
    Cancer Survivor, Sexual Dysfunction, Sexuality and Reproductive Issues, Unspecified Adult Solid Tumor, Protocol Specific
    Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma
    CCOP - Carle Cancer Center
    Urbana, Illinois 61801
    Multiple Myeloma, Plasma Cell Neoplasm
    Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Kidney Cancer
    Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
    CCOP - Carle Cancer Center
    Urbana, Illinois 61801
    Breast Cancer, Lung Cancer, Neurotoxicity, Ovarian Cancer, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Breast Cancer
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    CCOP - Carle Cancer Center
    Urbana, Illinois 61801
    Endometrial Cancer
    Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    CCOP - Carle Cancer Center
    Urbana, Illinois 61801
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
    CCOP - Carle Cancer Center
    Urbana, Illinois 61801
    Endometrial Cancer
    Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Breast Cancer, Hot Flashes
    Levocarnitine in Treating Fatigue in Cancer Patients
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Sarcoma
    A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
    Carle Clinic Association
    Urbana, Illinois 61801
    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
    Everolimus in Treating Patients With Stage IV Melanoma
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Melanoma (Skin)
    Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Sarcoma
    Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Lung Cancer
    S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Sarcoma
    ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Breast Cancer
    Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Pancreatic Cancer
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
    CCOP - Carle Cancer Center

    Trial Locations
    CCOP - Carle Cancer Center
    Carle Cancer Center at Carle Foundation Hospital
    Breast Cancer
    Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine
    Carle Cancer Center
    Urbana, Illinois 61801
    Prostate Cancer